Prevalence of chronic kidney disease in patients with various components of the metabolic syndrome requiring endovascular interventions, preliminary data from the Federal center: interim analysis

Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease and is a global burden with high economic costs for health systems. All stages of CKD are associated with an increased risk of cardiovascular events, premature mortality, and/or decreased quality of life. CKD is usually asymptomatic until the late stages, and accurate data on its prevalence are not available, including in the Russian Federation. In the medical literature, there are isolated works devoted to the study of the prevalence of CKD in patients with metabolic syndrome in a large population of patients, including those in need of various endovascular interventions that pose an additional risk of CKD progression. THE AIM: to study the prevalence of individual components of cardiorenometabolic syndrome depending on the presence of CKD in a sample of patients with cardiovascular disease planning endovascular intervention. PATIENT AND METHODS. The study included 9731 patients over 18 years of age, planning endovascular intervention. All patients were examined in accordance with Russian clinical guidelines. CKD C3a-C4 was diagnosed in 4378 patients. RESULTS. Patients with CKD were more likely to have diabetes mellitus, hypertension, atrial fibrillation and/or flutter, and CHF. Metabolic characteristics included higher body mass index, cholesterol, and CRP levels. CONCLUSION. Effective interdisciplinary collaboration between physicians of various specialties appears to be a key component of the management strategy for this patient population, with the aim of improving diagnostic and treatment algorithms and slowing the progression of cardiovascular disease and CKD.